TORAZZA, CAROLA
 Distribuzione geografica
Continente #
EU - Europa 3.613
AS - Asia 1.033
NA - Nord America 1.021
Continente sconosciuto - Info sul continente non disponibili 154
SA - Sud America 65
AF - Africa 14
OC - Oceania 3
Totale 5.903
Nazione #
IT - Italia 3.446
US - Stati Uniti d'America 956
SG - Singapore 370
CN - Cina 247
VN - Vietnam 172
BD - Bangladesh 140
BR - Brasile 43
HK - Hong Kong 35
CA - Canada 30
FI - Finlandia 28
FR - Francia 28
GB - Regno Unito 25
AR - Argentina 15
DE - Germania 13
MX - Messico 11
ES - Italia 10
JP - Giappone 10
IQ - Iraq 9
NL - Olanda 9
PL - Polonia 9
ID - Indonesia 8
JM - Giamaica 7
UA - Ucraina 7
CR - Costa Rica 6
IN - India 6
PH - Filippine 6
IE - Irlanda 5
TR - Turchia 5
DZ - Algeria 4
SA - Arabia Saudita 4
SI - Slovenia 4
AU - Australia 3
CH - Svizzera 3
HN - Honduras 3
MY - Malesia 3
PK - Pakistan 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
LT - Lituania 2
MD - Moldavia 2
PY - Paraguay 2
RO - Romania 2
RU - Federazione Russa 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
YT - Mayotte 1
Totale 5.749
Città #
Genoa 1.984
Genova 540
Vado Ligure 413
San Jose 290
Rapallo 215
Singapore 200
Ashburn 100
Council Bluffs 50
Ho Chi Minh City 50
Hanoi 43
Beijing 41
New York 40
Rome 38
Hong Kong 33
Los Angeles 28
Lauterbourg 22
Milan 21
Helsinki 20
Haiphong 17
Turin 17
Buffalo 13
Orem 13
Santa Clara 13
Bordighera 12
Naples 11
Montreal 10
Atlanta 9
Chicago 9
Osio Sopra 9
Da Nang 8
Lappeenranta 8
Mexico City 8
Frankfurt am Main 7
Kyiv 7
Messina 7
Staten Island 7
São Paulo 7
Bologna 6
Denton 6
Florence 6
Tokyo 6
Toronto 6
Baghdad 5
Boardman 5
Dallas 5
Dublin 5
Padua 5
Phoenix 5
Phủ Lý 5
Tianjin 5
Barcelona 4
Bari 4
Brooklyn 4
Denver 4
Detroit 4
Krakow 4
Ljubljana 4
Madrid 4
Piscataway 4
Salt Lake City 4
San José 4
Sydney 4
Tampa 4
Verona 4
Amsterdam 3
Basingstoke 3
Birmingham 3
Castellana Grotte 3
Changsha 3
Cisano Bergamasco 3
El Mirage 3
Hải Dương 3
Jakarta 3
Kingston 3
Kuala Lumpur 3
London 3
Malatya 3
Mugnano di Napoli 3
Paris 3
Pisa 3
San Salvador 3
The Dalles 3
Virginia Beach 3
Waco 3
Warsaw 3
Zurich 3
Akron 2
Albany 2
Albuquerque 2
Alexandria 2
Algiers 2
Amman 2
Arlington 2
Athens 2
Avezzano 2
Biên Hòa 2
Braga 2
Bratislava 2
Bắc Ninh 2
Bến Tre 2
Totale 4.540
Nome #
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 235
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 200
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 188
Metabotropic glutamate receptor 5 as a target for the modulation of the reactive astrocyte phenotype in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 172
Metabotropic glutamate receptor 5 as a potential target in ALS 167
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 162
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 146
TPP-Based Nanovesicles Kill MDR Neuroblastoma Cells and Induce Moderate ROS Increase, While Exerting Low Toxicity Towards Primary Cell Cultures: An In Vitro Study 144
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 143
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 140
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 137
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 133
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 132
The Role of Endoplasmic Reticulum in the Differential Endurance against Redox Stress in Cortical and Spinal Astrocytes from the Newborn SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis 131
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 129
Genetic and pharmacological effects by blocking mGlu5 Receptor in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 127
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 127
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 126
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 125
Sex Differences in CASA-Mediated Autophagy in ALS Glial Cells 122
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 118
Synthesized Bis-Triphenyl Phosphonium-Based Nano Vesicles Have Potent and Selective Antibacterial Effects on Several Clinically Relevant Superbugs 114
null 114
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 113
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 111
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells rescue glial activation in in-vitro models of amyotrophic lateral sclerosis 105
Micro-RNAs Shuttled by Extracellular Vesicles Secreted from Mesenchymal Stem Cells Dampen Astrocyte Pathological Activation and Support Neuroprotection in In-Vitro Models of ALS 105
Reducing mglur5 expression attenuates the reactive phenotype of astrocytes cultured from the spinal cord of late symptomatic SOD1G93A mice 103
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 100
Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine 97
Increased [18F]DPA-714 Uptake in the Skeletal Muscle of SOD1G93A Mice: A New Potential of Translocator Protein 18 kDa Imaging in Amyotrophic Lateral Sclerosis 94
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 94
MSC-derived extracellular vesicles for the treatment of ALS 91
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 85
The Impact of the Exposome on Alzheimer’s Disease: The Influence of Nutrition 84
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 81
The mGlu5 receptor negative allosteric modulator CTEP as a pharmacological tool to dampen ALS disease progression: in-vivo preclinical studies and clinical perspectives 78
Tri-Phenyl-Phosphonium-Based Nano Vesicles: A New In Vitro Nanomolar-Active Weapon to Eradicate PLX-Resistant Melanoma Cells 78
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 77
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 77
Reactive Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how mGlu5 receptor modulation affects pathological features 77
Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain 76
The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity 70
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 66
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 63
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 63
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 60
Reactive phenotype and oxidative stress in i-Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how the mGluR5 negative allosteric modulator CTEP affects these pathological features 56
The negative allosteric modulator CTEP ameliorates the reactive phenotype of human-derived iAstrocytes differentiated from iNPCs of patients affected by Amyotrophic Lateral Sclerosis 54
The negative allosteric modulator CTEP ameliorates the reactive phenotype of iastrocytes from patients affected by Amyotrophic Lateral Sclerosis 54
Behavioral profiling of G93A mice in ALS progression. 47
Decoding behavioral patterns in G93A mice: insights and implications. 47
Remarkable and Selective Cytotoxicity of Synthesized Bola-Amphiphilic Nano Vesicles on Etoposide-Sensitive and Resistant Neuroblastoma Cells 41
Focus on the excitatory and inhibitory neurotransmission imbalance in amyotrophic lateral sclerosis: a harmful disease player or a potential therapeutic opportunity? 38
null 36
Psychotropic drug-dependent modulation of excitatory-inhibitory balance in the prefrontal cortex of rats exposed to acute footshock stress 35
The Remarkable and Selective In Vitro Cytotoxicity of Synthesized Bola-Amphiphilic Nanovesicles on Etoposide-Sensitive and -Resistant Neuroblastoma Cells 34
The mGluR5 negative allosteric modulator CTEP reduces the aberrant activation and neurotoxicity of human-derived astrocytes differentiated from fibroblasts of ALS patients 29
In-vitro study on human-derived astrocytes showed the effects of mGluR5 negative allosteric modulator CTEP in reducing the aberrant activation and neurotoxicity of astroglial cells in ALS 19
Non-cell autonomous autophagy in amyotrophic lateral sclerosis: A new promising target? 13
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. 11
In-vitro validation of the safety profile, hepatoprotective activity and cellular internalization of the product Depurerbe® forte 8
null 1
Totale 5.903
Categoria #
all - tutte 18.297
article - articoli 8.844
book - libri 0
conference - conferenze 8.966
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022218 5 6 9 13 13 17 20 41 21 30 15 28
2022/2023282 22 30 4 25 28 34 5 22 47 4 53 8
2023/2024375 9 26 24 29 35 71 25 19 6 30 44 57
2024/20251.242 68 60 32 76 130 106 119 236 38 79 151 147
2025/20263.117 290 82 200 255 394 156 363 244 297 313 196 327
2026/2027287 287 0 0 0 0 0 0 0 0 0 0 0
Totale 5.903